Additional therapies for FA include the use of androgens to increase Hb and platelet counts, and granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) to treat neutropenia. This evidence concerns the gene GSTM1 and Friedreich ataxia.